MDCE Introduces a Higher Standard for Strain Integrity, Potency Verification and Agricultural Quality Control with StrainScan Pro (OTCID:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) unveiled the strategic role of its StrainScan Pro platform, a proprietary AI vision solution aimed at enhancing visual quality verification in regulated cannabis retail and large-scale agriculture. The system provides rapid, on-device analysis to support strain consistency, potency-related visual indicators, and quality checks for licensed operators.

According to the company, the same computer-vision architecture targets broader agricultural needs such as early pest and crop-illness detection and identification of visual anomalies that may indicate bacterial or quality issues. Deployed on iPad Air devices, StrainScan Pro is intended for use across farms, packing facilities, distribution points, and retail locations, enabling freshness and quality tracking from field to final destination. Medical Care Technologies emphasizes that it develops and commercializes AI vision software and does not handle cannabis or plant products directly, while continuing to expand AI solutions across health, wellness, nutrition, lifestyle, and enterprise imaging.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Proprietary AI Vision Platform Supports Product Authenticity in Cannabis Retail While Enabling Early Pest Detection, Crop Health Monitoring and Farm-to-Plate Freshness Tracking

MESA, AZ / ACCESS Newswire / August 18, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today highlighted the strategic potential of its StrainScan Pro platform as a proprietary AI vision solution designed to introduce a higher standard for visual quality verification across regulated retail and large-scale agriculture.

StrainScan Pro is designed to deliver rapid, on-device visual analysis that supports strain consistency, potency-related visual indicators, and quality verification for licensed operators. At the same time, the same core computer-vision architecture is positioned to address critical agricultural needs, including early detection of pests, crop illness, and visual anomalies that can signal bacterial or quality issues - challenges that have gained heightened industry attention following recent agricultural outbreaks.

The platform further supports freshness and quality tracking concepts from field to final destination, offering enterprise operators a portable tool that can be deployed on iPad Air devices across farms, packing facilities, distribution points, and retail environments.

"We believe StrainScan Pro can help introduce a higher standard for visual integrity and quality control," said Marshall Perkins, CEO of Medical Care Technologies. "Whether the goal is maintaining strain and quality standards in regulated retail or detecting threats to crop health early in the field, the technology is built to deliver consistent, scalable visual intelligence. Our focus is on giving operators a practical tool that protects value from the source to the end user."

Medical Care Technologies is a technology company. It develops and commercializes AI vision software and does not cultivate, process, distribute, or sell cannabis or any plant products.

The U.S. cannabis retail sector and the multi-trillion-dollar global agriculture market both face ongoing demands for greater consistency, traceability, and early-risk detection. StrainScan Pro is being positioned to meet those demands through a single proprietary platform.

Investors and industry participants can explore the platform at: https://strainscanpro.com

Medical Care Technologies continues to advance its AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.

About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTCID:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: marshall@medicalcaretechnologies.com Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is StrainScan Pro from Medical Care Technologies (OTCID:MDCE) and what does it do?

StrainScan Pro is a proprietary AI vision platform designed for rapid, on-device visual quality verification. According to Medical Care Technologies, it supports strain consistency, potency-related visual indicators, and quality checks for licensed cannabis retailers while extending to agricultural monitoring and farm-to-plate freshness tracking.

How does StrainScan Pro (MDCE) help cannabis retailers with strain integrity and potency verification?

StrainScan Pro provides visual analysis to help maintain strain consistency and monitor potency-related visual indicators. According to Medical Care Technologies, licensed operators can use the platform for standardized, on-device quality verification, supporting more consistent product presentation and integrity across regulated cannabis retail environments.

How can StrainScan Pro by MDCE be used in large-scale agriculture and crop health monitoring?

StrainScan Pro’s AI vision architecture is positioned to detect early signs of pests, crop illness, and visual anomalies. According to Medical Care Technologies, these capabilities support early-risk detection and quality assessment across farms, packing facilities, distribution points, and retail channels using portable iPad Air devices.

Does Medical Care Technologies (MDCE) cultivate or sell cannabis products with StrainScan Pro?

Medical Care Technologies does not cultivate, process, distribute, or sell cannabis or plant products. According to the company, it focuses on developing and commercializing AI vision software, with StrainScan Pro serving licensed operators and agricultural enterprises as a visual intelligence and quality-control tool.

How does StrainScan Pro (OTCID:MDCE) support farm-to-plate freshness and quality tracking?

StrainScan Pro supports freshness and quality tracking from field to final destination by enabling consistent visual inspections. According to Medical Care Technologies, operators can deploy the AI vision tool on iPad Air devices across farms, packing sites, distribution hubs, and retail locations to monitor visual quality indicators.

In which markets is Medical Care Technologies (MDCE) positioning the StrainScan Pro platform?

Medical Care Technologies is positioning StrainScan Pro for the U.S. cannabis retail sector and the global agriculture market. According to the company, both markets face growing needs for consistency, traceability, and early-risk detection, which the platform is intended to address through a single AI vision system.